Posts Tagged: "watson"

In 1992, Bill Clinton was elected President of the United States. Hurricane Andrew bore down on the American Southeast, causing billions in damage after wreaking destruction from Florida to Louisiana. Johnny Carson retired from The Tonight Show. The Buffalo Bills were in the Super Bowl. Los Angeles saw a string of deadly riots related to the LAPD’s televised beating of Rodney King. And 1992 was the last year during which a company other than American information technology firm IBM (NYSE:IBM) could claim that it had earned the greatest number of U.S. patents… With over 8,000 patents IBM stands supreme in the US patent world, earning the most US patents in 2016 and claiming the top spot for the 24th year in a row.

The first episode of Star Trek aired on September 8, 1966, some 50 years ago. Although the original series ended after only three rather disappointing seasons, the franchise would go on to spawn many sci-fi series and blockbuster movies. Star Trek has inspired generations of scientists and engineers, who continue to attempt to bring into being the gadgets and technology written into the story line. For example, several years ago the United States Patent Office issued a patent on the first cloaking device, last year scientists at the U.S. Naval Research laboratory created transparent aluminum, IBM’s omnipotent computer known as Watson can easily be likened to the all-knowing Star Trek computer, and a real-life food replicator can prepare a meal in 30 seconds. Of course, countless scientists have theorized about the possibility of a real life transporter, which is described as the holy grail of Star Trek technologies. Indeed, just a few months ago Russia embarked upon a path to achieve transporter technology within the next 20 years, and researchers believe through the use of quantum mechanics they can create a transporter-like device for data.

The law waits for no one and neither does AI, which has already made a lasting impact in many areas of business, including the practice of law. Contracts, e-discovery and overall legal research have all changed thanks to AI, but as computers driven by ever-increasing processing power exhibit extraordinarily intelligent behavior we can only assume such advances are far from over. Whether within the enterprise, partners, customers, opposing litigants or elsewhere, legal assets cannot hide from the likes of Watson—or for that matter HAL—or other budding or to-be-conceived AI platforms… Despite paranoia and hyperbole surrounding AI since 2001: A Space Odyssey, intelligent computers will not take over the world, although that premise does make for exciting science fiction. While the rise of the machines is not something one should fear, AI systems and their architects have made significant strides in realizing learning machines that can adapt to dense, arcane legal terminology.

Despite shrinking revenues, IBM may be able to chart its way back to stability if success continues for its Watson cognitive computing platform, the corporation’s fastest growing division by revenues and one which is proving applicable to a surprising range of industries. To profile IBM’s recent research and development related to Watson, we thought that we’d profile a series of data analytic and predictive modeling technologies for which IBM has been issued patents. For example, the evaluation of medical diagnoses for evaluating predictionaccuracy is detailed within U.S. Patent No. 9,235,808, entitled Evaluation of Predictions in the Absence of a Known Ground Truth. It claims a method to evaluate a prediction that a patient has a given disease by collecting a plurality of clinical data from each patient.

IBM once again has topped the list of annual U.S. patent recipients, receiving 7,355 patents in 2015. This is the 23rd consecutive year IBM has received more U.S. patents than any other entity in the world. More than 8,500 IBMers residing in 50 states and territories and 46 countries are responsible for IBM’s 2015 patent tally. IBM inventors who reside outside the U.S. contributed to more than 36 percent of the company’s 2015 patents.

The top two spots on the list of the 100 most valuable brands are occupied this year, as last year, by Apple Inc. (NASDAQ:AAPL) and Google Inc. (NASDAQ:GOOG), respectively. These two companies have held their respective spots since 2013, when both were able to ouster The Coca-Cola Co. (NYSE:KO) from the leading position in the Interbrand study, which it had held since Interbrand began releasing the report in 2000. Interbrand’s top 10 global brands include a collection of Companies We Follow often here on IPWatchdog, including 4th-placed Microsoft Corp. (NASDAQ:MSFT), 5th-placed IBM (NYSE:IBM), 7th-placed Samsung Electronics Co. (KRX:005930), 8th-placed General Electric Company (NYSE:GE) and 10th-placed Amazon.com, Inc. (NASDAQ:AMZN).

Just a few months after establishing this health and wellness cloud platform, IBM has secured its first Foundational Life Sciences partner for Watson Health in Teva Pharmaceutical Industries (NYSE:TEVA) of Petah Tikva, Israel. Statements from senior Teva officials indicate that the world’s largest manufacturer of generic pharmaceuticals will use the personal health cloud to connect more directly with physicians and patients and enable individualized treatment optimization options. It’s hoped that the Big Data tools available through IBM’s Watson analytics will be powerful enough to help Teva and others come up with more effective treatments for the millions of people worldwide suffering from chronic health conditions such as migraine, asthma or neurodegenerative diseases.

Skynet. HAL 9000. The Matrix. The Joshua Computer from WarGames. It’s not hard to look around popular culture and find examples of artificial intelligence (AI) stirring a span of doomsday fears stemming from either a lack of understanding of AI’s dangers to the actual targeting of humans by AI weapons. The names of Elon Musk, Steve Wozniak and Stephen Hawking, along with several faculty members from academic institutions like Oxford and the Massachusetts Institute of Technology, are among hundreds of signatures found attached to an open letter published by the Future of Life Institute which calls for “concrete research directions” to pursue for ensuring that AI remains a social benefit.

IBM is involved with the development of medical technologies for fields other than oncology, as is evidenced by the issue of U.S. Patent No. 9064306, which is titled Bidirectional Blood Vessel Segmentation. The method for segmenting blood vessels protected here involves receiving an angiogram frame, processing the angiogram frame by applying a Butterworth bandpass filter to suppress high and low frequency background noise, performing both bottom-up filtering and top-down segmentation of the angiogram frame and repeating that process until the results of the top-down segmentation from consecutive iterations equals or exceeds a threshold value. This process is useful for the analysis of angiogram images captured through cardiac catheterization as it can reduce the amount of feedback noise in those images.

IBM (NYSE: IBM) recently announced that it received a record number of patents during 2014, obtaining a staggering 7,534 U.S. patents in 2014. IBM is thoroughly committed to innovation. They do it because IBM has a culture of inventing, a culture of patenting, and over the years the company has invented and re-invented itself over and over. As you might expect, IBM is heavily involved in computers, particularly cloud computing and security. In fact, the company’s record-setting 2014 patent output was led by more than 3,000 patents – 40% of its overall annual total – covering a range of cloud computing, analytics, mobile, social and security inventions.